Navigation Links
Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma
Date:3/21/2013

all of the physicians, scientists and other professionals at CBMG, CSC and PLA 85 Hospital who have contributed to this work."

Multinational Contract Research Organization (CRO) CMIC-GCP has been contracted to manage the trial design and minimize delays.

Hepatocellular Carcinoma
Forty-five percent of the world's HCC patients are in China, with over 300,000 new patients diagnosed every year. Currently the therapies commonly offered to most patients are surgery and local chemotherapy, with a 2-year recurrence rate of 51% and median survival time of 13 months.

CBMG's research studies the effects of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy. Dr. William Cao , President of CBMG said, "In simplified terms, TC-DC therapy takes a sample of the patient's own dendritic, or immune cells and a sample of the patient's tumor stem cells and places them together in the lab. The dendritic cell will learn the characteristics of the tumor stem cells, and is reintroduced to the patient's body, where it can "train" the immune system to fight and destroy the tumor stem cells, which are the root cause of tumor recurrence and metastasis."

About Cellular Biomedicine Group
Cellular Biomedicine Group, Inc. develops proprietary cell therapies for the treatment of certain degenerative diseases and cancers.  Our developmental stem cell, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. Our flagship GMP facility, consisting of eight independent cell production lines, is designed, certified and managed according to U.S. standards.  To learn more about CBMG, please visit: www.cellbiomedgroup.com

Forward-Looking Statements
Statements in this press release relating to plans, strategies, trends,
'/>"/>

SOURCE Cellular Biomedicine Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cellular Dynamics Launches MyCellâ„¢ Services
2. Life Technologies and Cellular Dynamics International Partner for Global Commercialization of Novel Stem Cell Technologies
3. CeeTox and Cellular Dynamics Collaborate to Offer Predictive In Vitro Test for Cardiotoxicity Using Human iPSC-derived Cells
4. EastBridge Investment Group Announces Merger with Cellular Biomedicine Group
5. The Treatment Landscape for Hepatocellular Carcinoma Will Change Dramatically Over the Next Ten Years Due to the Launch of New Therapies in the United States and EU5
6. Arteriocyte Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors
7. Intra-Cellular Therapies Announces Completion of Phase I Single Rising Dose Trial of First-in-Class Selective Phosphodiesterase 1 (PDE1) Inhibitor and Reports Top-line Safety and Pharmacokinetic Findings
8. Cellular Dynamics Announces Presentations at the Society of Toxicologys 52nd Annual Meeting Demonstrating the Expanding Impact of iPSC-Derived Human Cells on Toxicology Assay Development
9. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
10. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
11. Watson to Acquire Actavis Group for EUR4.25 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014  CorMedix Inc. (NYSE MKT: ... commercializing therapeutic products for the prevention and treatment ... to announce that TUV-SUD and The Medicinal Evaluation ... (MEB) has granted its request for a label ... was initially approved in July 2013 for use ...
(Date:9/22/2014)... 2014 Thoratec Corporation (NASDAQ: THOR ... therapies to save, support and restore failing hearts, announced ... appointed President and Chief Executive Officer, effective immediately.  Mr. Grossman ... down from his executive and Board roles but will ... first quarter of 2016.  Mr. Grossman ...
(Date:9/22/2014)... 2014 Auxilium Pharmaceuticals, Inc. (NASDAQ: ... announced that its Board of Directors (the "Board") ... from Endo International plc ("Endo") and, after consulting ... unanimously determined it is not a superior proposal ... with QLT Inc. ("QLT") and has unanimously reaffirmed ...
Breaking Medicine Technology:Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 4Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 5Auxilium Provides Transaction Update 2Auxilium Provides Transaction Update 3Auxilium Provides Transaction Update 4Auxilium Provides Transaction Update 5Auxilium Provides Transaction Update 6
... 11, 2012  SuccessEHS announces that its newest release will ... when compared to previous releases.  The company has optimized ... (EHR) and Practice Management software solution ... upcoming release will focus on user efficiency and physician ...
... Jan. 11, 2012  nContact, Inc., the leading innovator ... recently launched corporate website, www.ncontactinc.com , has ... in Class Medical Site, presented by the nonprofit ... Studio 1440, has been recognized for excellence in ...
Cached Medicine Technology:Newest SuccessEHS Release to Increase Physician Software Usability 2Newest SuccessEHS Release to Increase Physician Software Usability 3nContact's Corporate Website Recognized as Best in Class Medical Site by Interactive Media Council - www.ncontactinc.com 2
(Date:9/22/2014)... 22, 2014 The Little Gym of ... Soles4Souls, a charitable organization based in Nashville, Tennessee that provides ... proper footwear. A pair of shoes can, seriously, change the ... on their feet. Confidence, comfort, and health are all improved ... of shoes to play, grown, and live. Aside from the ...
(Date:9/22/2014)... In a collaboration that will encompass a broad ... patient care and accelerate personalized genomic medicine, The ... Center (BIDMC) have established a new academic, research ... , A recently signed agreement calls for JAX ... comprehensive relationship in the areas of research and ...
(Date:9/22/2014)... 22, 2014 A team of doctors ... mesothelioma is better than ever thanks to ongoing improvements ... article on its website. Click here to read ... and the Massey Cancer Center analyzed the average survival ... type of mesothelioma that occurs in the abdominal lining. ...
(Date:9/22/2014)... CA (PRWEB) September 22, 2014 ... course from Winter & Alvin has just been ... excitement throughout the personal development community. The media ... attention of HonestyFirstReviews.com's Tiffany Hendricks prompting an investigative ... topic of great interest for many entrepreneurs and ...
(Date:9/22/2014)... The professional review website, Best Cheap Hosting ... companies and announced that Certified Hosting ( http://www.best-cheap-hosting-usa.com/go/CertifiedHosting/ ... hosting suppliers for webmasters who want to buy ... hosting) at affordable rates. , The spokesman for ... our customers will find many other creative ways ...
Breaking Medicine News(10 mins):Health News:The Little Gym of Houston and Stride Rite Partner to Support Soles4Souls 2Health News:The Jackson Laboratory and BIDMC announce multifaceted affiliation 2Health News:The Jackson Laboratory and BIDMC announce multifaceted affiliation 3Health News:Report Says New Treatments Have Dramatically Improved Outcomes for People with Peritoneal Mesothelioma, According to Surviving Mesothelioma 2Health News:"The Millionaire's Brain" - A Review Examining Winter & Alvin's Training Course Released 2
... James M. Farrell, a,doctor of chiropractic practicing in Golden, ... (CCA). He was nominated,and chosen by his fellow doctors ... since 1992, Dr. Farrell has been extremely active,with the ... chair, board member,and executive board member prior to his ...
... 2007 Today researchers report a newly identified ... prostate cancer in African American men. This study, ... with prostate cancer in high-risk populations, is published online ... Prostate cancer is the second leading cause of cancer ...
... scientists say , WEDNESDAY, Oct. 31 (HealthDay News) -- Scientists ... catus ), an advance they say will lead to health ... for human disease. , A four-year-old Abyssinian cat named Cinnamon, ... was the subject of the genome sequencing by scientists with ...
... WEDNESDAY, Oct. 31 (HealthDay News) -- Screening MRIs can uncover ... As a matter of fact, that might happen more than ... found that 7.2 percent of those who received MRIs had ... aneurysms, and 1.6 had benign brain tumors. , "Our study ...
... 31 The Medicare bidding,program for durable medical ... homecare infrastructure" unless Congress modifies,the program. This is ... a,congressional subcommittee today by the American Association for ... patients,standard of care, choice of provider, and access ...
... - Haemacure Corporation,(TSX:HAE), a specialty bio-therapeutics company, announces ... Rodman & Renshaw 9th Annual,Healthcare Conference, on November ... York,Palace Hotel in New York. Rodman & ... presentation and,post the associated slides via its website ...
Cached Medicine News:Health News:Golden Doctor of Chiropractic Elected President of the Colorado Chiropractic Association 2Health News:Scientists discover genetic variant associated with prostate cancer in African Americans 2Health News:Brain MRIs Find Hidden Neurological Problems 2Health News:Brain MRIs Find Hidden Neurological Problems 3Health News:Medicare Bidding for Durable Medical Equipment Will Harm Small Businesses and Seniors' Access to Care, American Association for Homecare Testifies 2Health News:Medicare Bidding for Durable Medical Equipment Will Harm Small Businesses and Seniors' Access to Care, American Association for Homecare Testifies 3Health News:Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec 2
... The ANA and ENA assays ... patients negative for antinuclear antibodies, which ... diseases such as Systemic lupus erythematosus ... disease, progressive systemic sclerosis, scleroderma, polymyositis, ...
... The ANA and ENA assays can ... negative for antinuclear antibodies, which are ... such as Systemic lupus erythematosus (Lupus), ... progressive systemic sclerosis, scleroderma, polymyositis, dermatomyositis, ...
... assays can be used to screen ... which are associated with various systemic ... erythematosus (Lupus), Sjgren's syndrome, mixed connective ... polymyositis, dermatomyositis, and Raynaud's phenomenon. They ...
... VerifyNow Clopidogrel Assay measures changes in ... taking Clopidogrel (Plavix). It uses a ... which clopidogrel inhibits. The assay has ... however, the assay is available for ...
Medicine Products: